IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
出版年份 2016 全文链接
标题
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume 12, Issue 8, Pages 849-855
出版商
Informa UK Limited
发表日期
2016-03-21
DOI
10.1586/1744666x.2016.1168293
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
- (2016) Rehana Akter et al. Journal of Diabetes Research
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
- (2015) Isabelle Koné-Paut et al. Expert Review of Clinical Immunology
- The Role of IL-1βin the Bone Loss during Rheumatic Diseases
- (2015) Piero Ruscitti et al. MEDIATORS OF INFLAMMATION
- Macrophages are essential for CTGF-mediated adult β-cell proliferation after injury
- (2015) Kimberly G. Riley et al. Molecular Metabolism
- FRI0219 Disease severity, no steroid use and type ii diabetes predict response to anakinra (kineret®) in patients with rheumatoid arthritis
- (2014) B. Missler-Karger et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance
- (2014) P. C. M. van Poppel et al. DIABETES OBESITY & METABOLISM
- Caspases and inflammasomes in metabolic inflammation
- (2014) Alexander M Skeldon et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Macrophages and islet inflammation in type 2 diabetes
- (2013) K. Eguchi et al. DIABETES OBESITY & METABOLISM
- Role of pancreaticβ-cell death and inflammation in diabetes
- (2013) W. Quan et al. DIABETES OBESITY & METABOLISM
- Macrophages control innate inflammation
- (2013) S. Akira et al. DIABETES OBESITY & METABOLISM
- Anakinra for cryopyrin-associated periodic syndrome
- (2013) Isabelle Koné-Paut et al. Expert Review of Clinical Immunology
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis
- (2013) Manathip Osiri et al. JOINT BONE SPINE
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Overview of the interleukin-1 family of ligands and receptors
- (2013) Charles A. Dinarello SEMINARS IN IMMUNOLOGY
- MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
- (2013) Sue Tsai et al. Frontiers in Immunology
- Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
- (2012) Kosei Eguchi et al. Cell Metabolism
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
- (2012) K. P. Liao et al. RHEUMATOLOGY
- Managing Macrophages in Rheumatoid Arthritis by Reform or Removal
- (2012) Jun Li et al. Current Rheumatology Reports
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Role of IL-1β in type 2 diabetes
- (2011) Charles A Dinarello et al. Current Opinion in Endocrinology Diabetes and Obesity
- Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells
- (2010) Guangjie Chen ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
- (2010) Marina K. Roell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic β-cell function
- (2010) Malek El Muayed et al. JOURNAL OF ENDOCRINOLOGY
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
- (2009) Marianne Böni-Schnetzler et al. ENDOCRINOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
- (2009) J. A. Ehses et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced Hyperglycemia
- (2008) Nadine S. Sauter et al. ENDOCRINOLOGY
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation
- (2008) Marianne Böni-Schnetzler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
- (2008) Rieke Alten et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search